Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Colonic Neoplasms 1Carcinoma 1

Interventions

pembrolizumab 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Cisplatin 4Taxes 3Platinum 3Paclitaxel 3Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3Radiotherapy, Intensity-Modulated 2peposertib 1ipatasertib 1dehydroftorafur 1cemiplimab 1atezolizumab 1X-Rays 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Radiation 1Pemetrexed 1Nutritional Status 1Immunoglobulin G 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Disulfides 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hypopharyngeal Neoplasms × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT05063552 2026-06-03

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
430 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡